SALSA - Study of Active Lifestyle Activation
SALSA - 积极生活方式激活研究
基本信息
- 批准号:10285925
- 负责人:
- 金额:$ 21.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-21 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerometerAdolescentAdultAgeAttitudeBlood PressureCancer SurvivorCardiotoxicityCardiovascular DiseasesCardiovascular systemCaringCause of DeathCessation of lifeChildChildhoodChildhood Cancer Survivor StudyChronic DiseaseCompetenceCounselingDecision MakingDevelopmentDiabetes MellitusDiagnosisDietDiet HabitsDietary FactorsDyslipidemiasExposure toFutureGeneral PopulationGoalsHealthHealthcareHealthcare SystemsHealthy EatingHeart failureHomeHypertensionInflammationInsulinInterventionIntervention StudiesLife StyleLipidsLong-Term SurvivorsMaintenanceMalignant NeoplasmsMediator of activation proteinMobile Health ApplicationMorbidity - disease rateMyocardial IschemiaNeighborhoodsOutcomeParticipantPharmacologyPhysical activityPhysiologicalPlayRandomizedRandomized Controlled TrialsResearchResearch DesignResourcesRiskRisk FactorsRoleSelf DeterminationSelf EfficacySelf ManagementSequential Multiple Assignment Randomized TrialSurvivorsTestingTimeTrainingTreatment EfficacyUnhealthy DietWomanactive lifestyleagedarmbasecancer therapycardiometabolismcardiovascular healthcardiovascular risk factorchildhood cancer survivorcohortdietaryexperiencefollow-upimprovedindexinginnovationintervention participantslifestyle factorslifestyle interventionmHealthmalignant breast neoplasmmodifiable riskmortalitypatient engagementpeer supportprematureprospectiverecruitremote deliveryresponsesecondary analysissedentarysexsocial mediasurvivorshiptelehealththeoriestreatment armtrial designyoung adult
项目摘要
PROJECT SUMMARY / ABSTRACT
Children and adolescents diagnosed with cancer now have, on average, nearly 85% 5-year survival. However,
premature cardiovascular (CV) disease has become the leading non-cancer cause of late mortality among
childhood cancer survivors. There is a robust body of evidence from the general population, and increasingly,
among cancer survivors (even those exposed to cardiotoxic cancer therapies), that greater physical activity (PA)
and improved diet quality can reduce future CV-related morbidity. However, while many general population and
cancer-specific intervention studies have focused on a single lifestyle factor (e.g., PA or diet alone), given the
interplay between PA and dietary factors in influencing CV health, a multi-faceted approach may result in overall
better long-term CV health profiles. Research on lifestyle interventions in cancer survivors also has been
predominantly conducted in women with breast cancer, and the evidence for survivors of childhood cancer is
limited. To accomplish our aims, we will use the largest prospectively followed childhood cancer survivor cohort
in the world, the Childhood Cancer Survivor Study (CCSS; n>24,000), to recruit adult-aged participants at
increased risk of early CV disease (n=403) for a remotely conducted 12-month randomized controlled trial testing
a multi-faceted approach at improving PA and diet quality. Specifically, the study will use a sequential multiple
assignment randomized trial (SMART) design, where participants with low PA or poor diet will first be randomized
between intervention and control conditions. Intervention participants will be further randomized to receive either
clinician-led telehealth sessions focused on risk factor self-management, or weekly mobile health (mHealth)
supported individualized PA and dietary goal-setting with social media peer support. The adaptive SMART
design will allow further tailoring of the intervention experience based on initial response, which may increase
overall intervention efficacy. Participants not initially responsive to their assigned intervention will be further
randomized to receive an alternate intervention. The study will use consumer-grade mHealth applications that
track PA and diet, thereby increasing future dissemination capacity. The study’s primary analyses will determine
the overall intervention efficacy and whether specific intervention strategies and sequence of strategies are
associated with optimal outcomes. Secondary analyses will examine potential predictors, mediators, and
moderating factors associated with PA and dietary changes over time, as well as changes in participants’
cardiometabolic profiles. In summary, lifestyle change represents one of the few available strategies to mitigate
CV risk in childhood cancer survivors. Significant barriers (e.g., time, training, resources) limit the ability of
healthcare systems to facilitate such change. To fill this void, remote-based, personalized, and easily
disseminated multi-faceted mHealth-supported interventions may play a transformative role.
项目总结/摘要
被诊断患有癌症的儿童和青少年现在平均有近85%的5年生存率。然而,在这方面,
早发心血管(CV)疾病已成为晚期死亡的主要非癌症原因,
儿童癌症幸存者。有一个强大的身体的证据,从一般人群,并越来越多,
在癌症幸存者中(即使是那些暴露于心脏毒性癌症治疗的人),
改善饮食质量可以降低未来CV相关的发病率。然而,尽管许多普通民众和
癌症特异性干预研究集中于单一的生活方式因素(例如,PA或单独饮食),
PA和饮食因素在影响CV健康方面的相互作用,多方面的方法可能会导致总体
更好的长期CV健康状况。对癌症幸存者生活方式干预的研究也一直在进行。
主要在乳腺癌妇女中进行,儿童癌症幸存者的证据是
有限公司为了实现我们的目标,我们将使用最大的前瞻性随访儿童癌症幸存者队列
在世界范围内,儿童癌症幸存者研究(CCSS; n> 24,000),招募成年参与者,
一项远程进行的12个月随机对照试验检测的早期CV疾病风险增加(n=403)
一个多方面的方法来改善PA和饮食质量。具体而言,该研究将使用连续多个
分配随机化试验(SMART)设计,其中PA低或饮食不良的受试者将首先随机化
干预和控制之间的关系。干预受试者将进一步随机接受
临床医生主导的远程医疗会议,重点是风险因素自我管理,或每周移动的健康(mHealth)
通过社交媒体同伴支持支持个性化PA和饮食目标设定。自适应SMART
设计将允许根据初步反应进一步调整干预经验,这可能会增加
整体干预效果。参与者最初对其分配的干预措施没有反应,
随机接受替代干预。该研究将使用消费级移动健康应用程序,
跟踪PA和饮食,从而提高未来的传播能力。这项研究的主要分析将确定
总体干预效果,以及具体的干预策略和策略顺序是否
与最佳结果相关。次要分析将检查潜在的预测因子、介导因子和
随着时间的推移,与PA和饮食变化相关的调节因素,以及参与者
心脏代谢特征总之,生活方式的改变是为数不多的缓解
儿童癌症幸存者的CV风险。重大障碍(例如,时间、培训、资源)限制了
医疗保健系统,以促进这种变化。为了填补这一空白,基于远程的、个性化的、轻松的
广泛传播的多方面移动保健支持的干预措施可能发挥变革作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Jessen Chow其他文献
Eric Jessen Chow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Jessen Chow', 18)}}的其他基金
SALSA - Study of Active Lifestyle Activation
SALSA - 积极生活方式激活研究
- 批准号:
10910785 - 财政年份:2021
- 资助金额:
$ 21.7万 - 项目类别:
SALSA - Study of Active Lifestyle Activation
SALSA - 积极生活方式激活研究
- 批准号:
10601394 - 财政年份:2021
- 资助金额:
$ 21.7万 - 项目类别:
Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators
改善拉丁裔幸存者的癌症生存护理服务:远程医疗
- 批准号:
10603034 - 财政年份:2021
- 资助金额:
$ 21.7万 - 项目类别:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
右雷佐生与蒽环类药物相关心肌病的预防
- 批准号:
9220377 - 财政年份:2017
- 资助金额:
$ 21.7万 - 项目类别:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
右雷佐生与蒽环类药物相关心肌病的预防
- 批准号:
9891037 - 财政年份:2017
- 资助金额:
$ 21.7万 - 项目类别:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
右雷佐生与蒽环类药物相关心肌病的预防
- 批准号:
10656913 - 财政年份:2017
- 资助金额:
$ 21.7万 - 项目类别:
Improving treatment of cardiovascular risk factors in childhood cancer survivors
改善儿童癌症幸存者心血管危险因素的治疗
- 批准号:
10603027 - 财政年份:2017
- 资助金额:
$ 21.7万 - 项目类别:
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
造血细胞移植存活率及死亡率分析
- 批准号:
8641672 - 财政年份:2013
- 资助金额:
$ 21.7万 - 项目类别:
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
造血细胞移植存活率及死亡率分析
- 批准号:
8513119 - 财政年份:2013
- 资助金额:
$ 21.7万 - 项目类别:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
造血细胞癌幸存者晚期心血管发病的决定因素
- 批准号:
8893907 - 财政年份:2011
- 资助金额:
$ 21.7万 - 项目类别:
相似海外基金
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
- 批准号:
10755168 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
- 批准号:
480840 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
- 批准号:
10744412 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
- 批准号:
23K07305 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
- 批准号:
23H02874 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
- 批准号:
10756652 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
- 批准号:
10730872 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
- 批准号:
10650648 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别: